This illustration maps potential non-motor features of Parkinson’s disease onto the human body, showing how the disease can affect systems beyond movement, including mood, cognition, sleep, the senses, and autonomic functions such as digestion and blood pressure (adapted from Schapira et al., 2017).1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
Related content
Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease
Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure
Illustration of how COMT inhibitors increase dopamine availability in Parkinson’s disease by preventing the breakdown of L-DOPA